Population Pharmacokinetics of Elagolix in Combination with Low-Dose Estradiol/Norethindrone Acetate in Women with Uterine Fibroids.
Denise BeckInsa WinzenborgMohan LiuJacob F DegnerNael M MostafaPeter NoertersheuserMohamad ShebleyPublished in: Clinical pharmacokinetics (2021)
ClinicalTrials.gov identifiers: NCT01620528 (EM-1), NCT01760954 (EM-1-Extend), NCT01931670 (EM-2), NCT02143713 (EM-2-Extend), NCT02654054 (UF-1), NCT02691494 (UF-2), NCT0295494 (UF-Extend).
Keyphrases